GH1 and depressive symptom measurement: Depression and chronic stress activate the hypothalamic–pituitary–adrenal axis, raise catabolic cortisol, suppress sex steroids and growth hormone, down-regulate mammalian target of rapamycin complex 1 (mTORC1) signaling, and amplify systemic inflammation—all established mechanisms in sarcopenia pathophysiology (24–26).